Thomas (TC) Chan, Chief Accounting Officer of GoodRx Holdings, Inc. (NASDAQ:GDRX), filed a Form 4 on September 15, 2026, disclosing the vesting of restricted stock units and a related tax-withholding disposition of Class A Common Stock on the same date.

Key Highlights

  • RSU vesting: 2,101 restricted stock units converted to 2,101 shares of Class A Common Stock on September 15, 2026, via transaction code M.
  • Shares withheld for taxes: 1,069 shares of Class A Common Stock were disposed of (transaction code F) at $3.56 per share on September 15, 2026.
  • Remaining direct ownership: Chan directly holds 14,578 shares of Class A Common Stock following these transactions.
  • Remaining derivative holdings: 12,606 restricted stock units remain beneficially owned directly after the reported vesting.
  • Vesting schedule: The RSU award vests in 1/16 increments in quarterly installments beginning June 15, 2024, subject to continued service through each vesting date.
  • Signing authority: The form was signed by Gracye Cheng as Attorney-in-Fact for Thomas (TC) Chan.

GoodRx CAO Chan Discloses Quarterly RSU Vest and Tax Withholding on September 15, 2026

According to the filing, Thomas (TC) Chan, who serves as Chief Accounting Officer of GoodRx Holdings, Inc., reported two transactions in Table I involving Class A Common Stock. First, 2,101 shares were acquired (code M) upon the conversion of an equal number of restricted stock units. Second, 1,069 of those shares were disposed of (code F) at a price of $3.56 per share, a transaction type typically associated with shares withheld to satisfy tax obligations. Following both transactions, Chan directly beneficially owned 14,578 shares of Class A Common Stock.

In Table II, the filing reports that the 2,101 restricted stock units that vested carry a derivative security price of $0 and that each unit represents a contingent right to receive one share of Class A Common Stock. After the vesting event, Chan directly holds 12,606 restricted stock units. The filing states that this RSU award vests with respect to 1/16 of the total award in quarterly installments beginning June 15, 2024, and on each quarterly anniversary thereafter, subject to the reporting person's continued service through each applicable vesting date.

The form was filed as an individual filing by one reporting person. It was signed on September 15, 2026, by Gracye Cheng as Attorney-in-Fact for Thomas (TC) Chan. No amendment date was listed, indicating this is an original filing.

What Was Disclosed

The filing discloses the vesting of 2,101 restricted stock units into Class A Common Stock and the concurrent withholding of 1,069 shares at $3.56 each, with Chan retaining direct ownership of 14,578 shares and 12,606 remaining RSUs as of September 15, 2026.